Idiopathic Pulmonary Fibrosis Clinical Trials

A listing of Idiopathic Pulmonary Fibrosis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 239 clinical trials
None
Structured Exercise Training Programme in Idiopathic Pulmonary Fibrosis

, symptoms and health related quality of life in patients with Idiopathic Pulmonary Fibrosis (IPF). We also wish to assess the effect of exercise training on fibrotic processes causing IPF through

dyspnea
hypersensitivity pneumonitis
idiopathic pulmonary fibrosis
interstitial lung disease
pneumonia
  • 30 views
  • 24 Jan, 2021
  • 1 location
None
Autoantibody Reduction for Acute Exacerbations of Idiopathic Pulmonary Fibrosis

Acute exacerbations (AE) are a dreaded manifestation of idiopathic pulmonary fibrosis (IPF) that presents with rapidly worsening respiratory function over days to weeks. AE account for about 1/2

  • 33 views
  • 13 Oct, 2021
  • 6 locations
None
Treating People With Idiopathic Pulmonary Fibrosis With the Addition of Lansoprazole

IPF is a progressive scarring lung condition causing coughing and breathlessness. IPF patients often have reflux disease meaning stomach acid may be breathed into the lungs, potentially damaging

idiopathic pulmonary fibrosis
scarring
  • 0 views
  • 22 Jul, 2021
  • 1 location
None
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IPF

This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of Idiopathic pulmonary

idiopathic pulmonary fibrosis
  • 0 views
  • 02 Sep, 2021
  • 1 location
None
A Multicenter Trial to Evaluate the Efficacy Safety and Tolerability of HZN-825 in Subjects With Idiopathic Pulmonary Fibrosis

This is a randomized, double-blind, placebo-controlled, repeat-dose, multicenter trial to evaluate the efficacy, safety and tolerability of HZN-825 in subjects with IPF. Subjects will be

emphysema
idiopathic pulmonary fibrosis
diffusion capacity of the lung for carbon monoxide
pneumonia
nintedanib
  • 0 views
  • 11 Sep, 2021
  • 3 locations
None
Clinical Efficacy and Safety of Autologous Lung Stem Cell Transplantation in Patients With Idiopathic Pulmonary Fibrosis

Idiopathic pulmonary fibrosis (IPF) is a chronic and ultimately fatal disease characterized by a progressive damage of lung structure and decline in lung function.This study intends to carry out

bronchoscopy
idiopathic pulmonary fibrosis
pulmonary function test
  • 0 views
  • 24 Jan, 2021
  • 2 locations
None
High Oxygen Delivery to Preserve Exercise Capacity in Idiopathic Pulmonary Fibrosis Patients Treated With Nintedanib

Glaucoma is a progressive optical neuropathy, generally associated with ocular hypertension. The treatment aims to stabilize the visual field deficiencies by lowering the intraocular pressure. Due to the fluctuation of the visual field test and re-test measures, the European recommendations are to obtain 6 visual field tests in 2 years …

dyspnea
idiopathic pulmonary fibrosis
pulmonary rehabilitation
pulse oximetry at rest
hypertension
  • 221 views
  • 24 Jan, 2021
  • 8 locations
None
Fibroblast Specific Inhibition of LOXL2 and TGFbeta1 Signaling in Patients With Pulmonary Fibrosis.

This is a two part study. In the first part, the pharmacokinetic profile of Epigallocatechin-3-gallate (EGCG) in normal human volunteers given a single oral dose will be determined to set the dose for the second part of the study. In the second part of this study, lung biopsy fragments and …

interstitial lung disease
pulmonary disease
lung biopsy
  • 19 views
  • 03 Feb, 2021
  • 1 location
None
Safety Tolerability and Pharmacokinetic Study of TRK-250 for Patients With Idiopathic Pulmonary Fibrosis

of TRK-250 in subjects with idiopathic pulmonary fibrosis (IPF).

idiopathic pulmonary fibrosis
diffusion capacity of the lung for carbon monoxide
  • 170 views
  • 23 May, 2021
  • 13 locations
None
TD-1058 First-In-Human Study in Healthy Subjects and Subjects With Idiopathic Pulmonary Fibrosis

is a SAD study in healthy subjects, Part B is a MAD study in healthy subjects, and Part C is a multiple-dose study in subjects with IPF.

carbon monoxide
idiopathic pulmonary fibrosis
body mass index
diffusion capacity of the lung for carbon monoxide
spirometry
  • 0 views
  • 27 Apr, 2021
  • 1 location